In a market obsessed with flashy IPOs and billion-dollar valuations, Cytotheryx operates quietly from Ann Arbor, Michigan, solving one of biotech's most persistent bottlenecks: reliable human liver cells. With just 18 employees generating $2.8M in revenue, they're not building the next AI drug discovery platform—they're supplying the literal cells that make discovery possible.

"They're not chasing the AI hype cycle—they're selling the biological infrastructure that AI models are trained on."

The tech stack reveals a modern, functional approach: Tailwind CSS for rapid development, Swiper for product showcases, and Google Analytics for tracking their niche audience. No fancy React frameworks or blockchain integrations—just reliable tools for a business that prioritizes function over flash. Their LinkedIn presence and blog resources suggest they're building thought leadership in a space where trust is currency.

• Revenue per employee: ~$155K—indicating high-value, specialized products
• Traffic quality over quantity: 1,809 visits with 61% organic suggests highly targeted audience
• No social media noise: Minimal Twitter presence, focused LinkedIn strategy
• Direct sales model: 20% direct traffic shows strong brand recall in niche markets